Cutaneous vaccination: Antigen delivery into or onto the skin

Vaccine

Volumn 31, Issue 34, 2013, Pages 3389-3391

  Weniger, Bruce G ^a   Glenn, Gregory M ^b  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b NOVAVAX INC   (United States)

Author keywords

Cutaneous vaccination; Immunization; Intradermal vaccination; Jet injection; Microneedles; Nomenclature; Vaccine delivery

Indexed keywords

INFLUENZA VACCINE; MEASLES VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

CUTANEOUS VACCINATION; DRUG DELIVERY SYSTEM; EDITORIAL; HUMAN; MININEEDLE; NEEDLE; PRIORITY JOURNAL; SKIN; SYRINGE; VACCINATION;

CUTANEOUS VACCINATION; IMMUNIZATION; INTRADERMAL VACCINATION; JET INJECTION; MICRONEEDLES; NOMENCLATURE; VACCINE DELIVERY;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIGENS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; INJECTIONS, INTRADERMAL; NEEDLES; SKIN; TRANSDERMAL PATCH; VACCINATION; VACCINES;

EID: 84880514153     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.05.048     Document Type: Editorial

References (22)

1. Weniger B.G., Papania M.J. Alternative vaccine delivery methods. Vaccines 2013, 1200-1231. Elsevier/Saunders, Philadelphia, (Chapter 61). 6th ed. S.A. Plotkin, W.A. Orenstein, P.A. Offit (Eds.).
2. Sakula A. Paul Langerhans (1847-1888): a centenary tribute. J R Soc Med 1988, 81(7):414-415.
3. Mohammed A.J., AlAwaidy S., Bawikar S., Kurup P.J., Elamir E., Shaban M.M.A., et al. Fractional doses of inactivated poliovirus vaccine in Oman. N Engl J Med 2010, 362:2351-2359. 10.1056/NEJMoa0909383.
4. Resik S., Tejeda A., Sutter R.W., Diaz M., Sarmiento L., Alemañi N., et al. Priming after a fractional dose of inactivated poliovirus vaccine. N Engl J Med 2013, 368:416-424. 10.1056/NEJMoa1202541.
5. Frech S.A., Dupont H.L., Bourgeois A.L., McKenzie R., Belkind-Gerson J., Figueroa J.F., et al. Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet 2008, 371(9629):2019-2025. 10.1016/S0140-6736(08)60839-9.
6. de Oliveira L.H., Danovaro-Holliday M.C., Ruiz Matus C., Andrus J.K. Rotavirus vaccine introduction in the Americas: progress and lessons learned. Expert Rev Vaccines 2008, 7(3):345-353. 10.1586/14760584.7.3.345.
7. Glenn G.M., Kenney R.T. Mass vaccination: solutions in the skin. Curr Topics Microbiol Immunol 2006, 304:247-268. 10.1007/3-540-36583-4_14.
8. Murphy T.V., Gargiullo P.M., Massoudi M.S., Nelson D.B., Jumaan A.O., Okoro C.A., et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001, 344(8):564-572. 10.1056/NEJM200102223440804.
9. Mutsch M., Zhou W., Rhodes P., Bopp M., Chen R.T., Linder T., et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 2004, 350(9):896-903. 10.1056/NEJMoa030595.
10. Henao-Restrepo A.M., Greco M., Laurie X., John O., Aguado T. WHO Product Development Group for Measles Aerosol Project, Measles Aerosol Vaccine Project. Proc Vaccinol 2010, 2:147-150. 10.1016/j.provac.2010.07.007.
11. Pasteur L. Compte rendu sommaire des expériences faites à Pouilly-le-Fort, près Melun, sur la vaccination charbonneuse (avec la collaboration de MM. Chamberland et Roux). C R Acad Sci (Paris) 1881, 92:1378-1383.
12. Zehrung D., Jarrahian C., Wales A. Intradermal delivery for vaccine dose sparing: overview of current issues. Vaccine 2013, 31:3392-3395.
13. Moon S., Wang Y., Edens C., Gentsch J.R., Prausnitz M.R., Jiang B. Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch. Vaccine 2013, 31:3396-3402.
14. Edens C., Collins M.L., Ayers J., Rota P.A., Prausnitz M.R. Measles vaccination using a microneedle patch. Vaccine 2013, 31:3403-3409.
15. Ploemen I.H., Chakravarty S., van Gemert G.-J.J., Annoura T., Khan S.M., Janse C.J., et al. Plasmodium liver load following parenteral sporozoite administration in rodents. Vaccine 2013, 31:3410-3416.
16. Novotny L.A., Clements J.D., Bakaletz L.O. Kinetic analysis and evaluation of the mechanisms involved in the resolution of experimental nontypeable Haemophilus influenzae-induced otitis media after transcutaneous immunization. Vaccine 2013, 31:3417-3426.
17. Hessenberger M., Weiss R., Weinberger E.E., Boehler C., Thalhamer J., Scheiblhofer S. Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores. Vaccine 2013, 31:3427-3434.
18. Kommareddy S., Baudner B.C., Bonificio A., Gallorini S., Palladino G., Determan A.S., et al. Influenza subunit vaccine coated microstructure patches elicit comparable immune responses to intramuscular injection in guinea pigs. Vaccine 2013, 31:3435-3441.
19. Mittal A., Raber A.S., Schaefer U.F., Weissmann S., Ebensen T., Schulze K., Guzmán C.A., Lehr C.-M., Hansen S. Non-invasive delivery of nanoparticles to hair follicles - a perspective for transcutaneous immunization. Vaccine 2013, 31:3442-3451.
20. Nelson E.A.S., Lam H.S., Choi K.C., Ho W.C.S., Fung L.-W.E., Cheng F.W.T., et al. A pilot randomised study to assess immunogenicity, reactogenicity, safety and tolerability of two human papillomavirus vaccines administered intramuscularly and intradermally to females aged 18 to 26 years. Vaccine 2013, 31:3452-3460.
21. Abate T. Aviron flu vaccine rebuffed by FDA panel/Advisers cite safety concerns. San Francisco Chronicle [newspaper] 2001, 28 July, http://www.sfgate.com/business/article/Aviron-flu-vaccine-rebuffed-by-FDA-panel-2895990.php.
22. Barbaro M. MedImmune to try new FluMist tactic. Washington Post [newspaper] 2004, 16 June, p. E01, http://www.washingtonpost.com/wp-dyn/articles/A44947-2004Jun15.html.